Use of amplatzer fenestrated atrial septal defect device in a child with familial pulmonary hypertension

Alain Fraisse, Philippe Chetaille, Zahid Amin, Francis Rouault, Marc Humbert

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

In a 4.5-year-old child with refractory pulmonary arterial hypertension, we performed atrial septostomy with the application of an Amplatzer fenestrated device designed to maintain patency. Continuous intravenous epoprostenol infusion was started concomitantly. Forty-two months after the procedure, the patient had no recurrent syncope and remained in New York Heart Association functional class II. Fenestration of the atrial septum is feasible in children with pulmonary artery hypertension. No conclusion regarding the patient's need for an atrial septal defect can be drawn since concomitant prostanoid therapy was administered. The long-term patency of the atrial communication needs further confirmation and the optimal timing for its application has to be determined.

Original languageEnglish (US)
Pages (from-to)759-762
Number of pages4
JournalPediatric Cardiology
Volume27
Issue number6
DOIs
StatePublished - Dec 1 2006
Externally publishedYes

Fingerprint

Atrial Heart Septal Defects
Pulmonary Hypertension
Atrial Septum
Equipment and Supplies
Syncope
Epoprostenol
Intravenous Infusions
Pulmonary Artery
Prostaglandins
Communication
Therapeutics

Keywords

  • Atrial septostomy
  • Interventional catheterization
  • Pulmonary arterial hypertension

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this

Use of amplatzer fenestrated atrial septal defect device in a child with familial pulmonary hypertension. / Fraisse, Alain; Chetaille, Philippe; Amin, Zahid; Rouault, Francis; Humbert, Marc.

In: Pediatric Cardiology, Vol. 27, No. 6, 01.12.2006, p. 759-762.

Research output: Contribution to journalArticle

Fraisse, Alain ; Chetaille, Philippe ; Amin, Zahid ; Rouault, Francis ; Humbert, Marc. / Use of amplatzer fenestrated atrial septal defect device in a child with familial pulmonary hypertension. In: Pediatric Cardiology. 2006 ; Vol. 27, No. 6. pp. 759-762.
@article{63c9b85eaa4849539d41481698e5c7d6,
title = "Use of amplatzer fenestrated atrial septal defect device in a child with familial pulmonary hypertension",
abstract = "In a 4.5-year-old child with refractory pulmonary arterial hypertension, we performed atrial septostomy with the application of an Amplatzer fenestrated device designed to maintain patency. Continuous intravenous epoprostenol infusion was started concomitantly. Forty-two months after the procedure, the patient had no recurrent syncope and remained in New York Heart Association functional class II. Fenestration of the atrial septum is feasible in children with pulmonary artery hypertension. No conclusion regarding the patient's need for an atrial septal defect can be drawn since concomitant prostanoid therapy was administered. The long-term patency of the atrial communication needs further confirmation and the optimal timing for its application has to be determined.",
keywords = "Atrial septostomy, Interventional catheterization, Pulmonary arterial hypertension",
author = "Alain Fraisse and Philippe Chetaille and Zahid Amin and Francis Rouault and Marc Humbert",
year = "2006",
month = "12",
day = "1",
doi = "10.1007/s00246-006-1325-0",
language = "English (US)",
volume = "27",
pages = "759--762",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Use of amplatzer fenestrated atrial septal defect device in a child with familial pulmonary hypertension

AU - Fraisse, Alain

AU - Chetaille, Philippe

AU - Amin, Zahid

AU - Rouault, Francis

AU - Humbert, Marc

PY - 2006/12/1

Y1 - 2006/12/1

N2 - In a 4.5-year-old child with refractory pulmonary arterial hypertension, we performed atrial septostomy with the application of an Amplatzer fenestrated device designed to maintain patency. Continuous intravenous epoprostenol infusion was started concomitantly. Forty-two months after the procedure, the patient had no recurrent syncope and remained in New York Heart Association functional class II. Fenestration of the atrial septum is feasible in children with pulmonary artery hypertension. No conclusion regarding the patient's need for an atrial septal defect can be drawn since concomitant prostanoid therapy was administered. The long-term patency of the atrial communication needs further confirmation and the optimal timing for its application has to be determined.

AB - In a 4.5-year-old child with refractory pulmonary arterial hypertension, we performed atrial septostomy with the application of an Amplatzer fenestrated device designed to maintain patency. Continuous intravenous epoprostenol infusion was started concomitantly. Forty-two months after the procedure, the patient had no recurrent syncope and remained in New York Heart Association functional class II. Fenestration of the atrial septum is feasible in children with pulmonary artery hypertension. No conclusion regarding the patient's need for an atrial septal defect can be drawn since concomitant prostanoid therapy was administered. The long-term patency of the atrial communication needs further confirmation and the optimal timing for its application has to be determined.

KW - Atrial septostomy

KW - Interventional catheterization

KW - Pulmonary arterial hypertension

UR - http://www.scopus.com/inward/record.url?scp=33845481293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845481293&partnerID=8YFLogxK

U2 - 10.1007/s00246-006-1325-0

DO - 10.1007/s00246-006-1325-0

M3 - Article

VL - 27

SP - 759

EP - 762

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 6

ER -